Healsun Biopharm
Hangzhou
About Healsun Biopharm
Healsun Biopharm is a high-tech antibody/recombinant protein CRO/CDMO company, offering end-to-end service by multiple platforms from early developability assessments, stable cell line construction, culture medium customization, process development (including ADC), to pilot production, IND application and clinical production.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Total funding: $101.3M
- Funding stage: Late Stage Venture
- Last round: Series C (Nov 2025)
- Website: hs-biopharm.com
- Phone: 0571-26201624
Industries & Categories
Biopharma, Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/healsun-biopharm-75187 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.